Assessment of Coronary Flow Reserve by PET-H215O and FFR. Comparison With Dynamic Acquisition Using CZT Camera
NCT ID: NCT02278497
Last Updated: 2015-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2014-11-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ASSESSMENT OF CORONARY FLOW RESERVE BY PET-H215O AND FFR
ASSESSMENT OF CORONARY FLOW RESERVE BY PET-H215O AND FFR
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ASSESSMENT OF CORONARY FLOW RESERVE BY PET-H215O AND FFR
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suspected coronary disease and / or coronary syndrome patient ST-
* Patient who has been informed of the study and has given his informed consent
* Patient affiliated to a social security system.
Exclusion Criteria
* Delay of Care grater than 30 days between the PET and SPECT imaging and the diagnostic coronary angiography
* Patient with a recent history of myocardial infarction and STEMI, unstable angina
* Patient with extra-cardiac disease whose prognosis can interfere with the treatment decision
* Pregnant or lactating women
* Patient allergic to contrast products during coronary angiography
* Patient with MDRD clearance les than 60 ml / min
* Patient Under guardianship, or unable to understand the purpose of the study
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spectrum Dynamics
INDUSTRY
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medecine Nucleaire
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Denis Agostini, MD,PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-006
Identifier Type: -
Identifier Source: org_study_id